On the recordSeptember 18, 2014
But there is something to say for the profit motive as well.
Source
congress.govEditor's note · Context
Gingrey supports the profit motive in pharmaceutical research to drive innovation.
Share & report
More from Phil Gingrey
Jul 18, 2012
I want to thank the witnesses. I think you all three have been very forthright and haven't dodged any of the tough questions.
Mar 14, 2013
I feel very strongly that the States should be able to do that, and that is what this bill, the Liberty Act, is about.
Mar 14, 2013
This is a bipartisan bill. I would like to again urge my colleagues to sign on to it.
Mar 19, 2013
An overly restrictive regulatory process will stifle innovation and ultimately lead to erosion in the quality of care.
Other voices in this conversation
